1-4 of 4
Richard Beswick
Close
Sort by
Journal Articles

The EQ-5D-5L Predicts Treatment Outcomes and Provides Added Value to the R-IPSS in Patients with MDS, CMML or AML Treated within the Austrian Azacitidine Registry - a Prospective Cohort Study By the AGMT Study Group

Lisa Pleyer, Sonja Heibl, Christoph Tinchon, Sonja Vallet, Branka Petricevic, Michael Leisch, Alexander Egle, Thomas Melchardt, Gudrun Piringer, Dominik Wolf, Richard Beswick, Manuel Drost, Julian Larcher-Senn, Thomas Grochtdreis, Richard Greil, Reinhard Stauder
Journal: Blood
Blood (2021) 138 (Supplement 1): 64.
https://doi.org/10.1182/blood-2021-145281
Published: 2021
Journal Articles

Defective Telomerase in Familial Myelodysplasia and Leukemia

Michael Kirwan, Tom Vulliamy, Amanda J. Walne, Richard Beswick, Peter Hillmen, Richard Kelly, Andrew Stewart, David Bowen, Stefan Schonland, Annika Maria Whittle, Tony McVerry, Maria Gilleece, Inderjeet Dokal
Journal: Blood
Blood (2008) 112 (11): 849.
https://doi.org/10.1182/blood.V112.11.849.849
Published: 2008
Journal Articles

TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes

Amanda J. Walne, Tom Vulliamy, Richard Beswick, Michael Kirwan, Inderjeet Dokal
Journal: Blood
Blood (2008) 112 (9): 3594–3600.
https://doi.org/10.1182/blood-2008-05-153445
Published: 2008
Journal Articles

Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome

Anna Marrone, Amanda Walne, Hannah Tamary, Yuka Masunari, Michael Kirwan, Richard Beswick, Tom Vulliamy, Inderjeet Dokal
Journal: Blood
Blood (2007) 110 (13): 4198–4205.
https://doi.org/10.1182/blood-2006-12-062851
Published: 2007